Long-term safety, tolerability and efficacy of bosentan in adults with pulmonary arterial hypertension associated with congenital heart disease


Creative Commons License

Diller G., Dimopoulos K., KAYA M. G. , Harries C., Uebing A., Li W., ...More

HEART, vol.93, no.8, pp.974-976, 2007 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 93 Issue: 8
  • Publication Date: 2007
  • Doi Number: 10.1136/hrt.2006.089185
  • Title of Journal : HEART
  • Page Numbers: pp.974-976

Abstract

Objective: To examine long-term safety and efficacy of bosentan - an oral dual endothelin receptor antagonist - in patients with pulmonary hypertension associated with congenital heart disease or Eisenmenger's syndrome.